## **Core Concept**
Digoxin toxicity can occur due to various factors that affect its pharmacokinetics or pharmacodynamics. The risk of digoxin toxicity is increased in conditions that alter the drug's levels, its binding to cardiac receptors, or the patient's underlying cardiac or renal function.

## **Why the Correct Answer is Right**
Hypokalemia increases the risk of digoxin toxicity. Digoxin and potassium compete for binding sites on the cardiac cell membrane. When potassium levels are low, more digoxin binds to the cardiac cells, increasing its effect and toxicity. Additionally, hypokalemia can also increase the reabsorption of digoxin in the kidneys, further elevating its levels.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Hypercalcemia does not directly increase the risk of digoxin toxicity in the same way hypokalemia does, although electrolyte imbalances are critical. However, it can potentiate the effects of digoxin indirectly.
- **Option B:** Hypermagnesemia is not typically highlighted as a direct risk factor for digoxin toxicity.
- **Option C:** This option is not provided, but based on common factors, conditions like renal impairment, which affects digoxin clearance, are well-known risk factors.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that **digoxin toxicity can be potentiated by hypokalemia, hypomagnesemia, and hypercalcemia**. Monitoring and managing electrolytes is crucial in patients on digoxin therapy. A classic clinical scenario is a patient with atrial fibrillation on digoxin who develops hypokalemia and subsequently shows signs of digoxin toxicity.

## **Correct Answer:** . Hypokalemia